EXPLORE CONNECTIONS
Improving phase II oncology trials using best observed RECIST response as an endpoint by modelling continuous tumour measurements
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.